JASIC(SZ:300193)2020-04-24 16:00Financial Performance - Total revenue for Q1 2020 was ¥141,479,478.04, a decrease of 30.01% compared to ¥202,146,254.28 in the same period last year[8] - Net profit attributable to shareholders was ¥28,702,752.11, down 2.98% from ¥29,584,430.88 year-on-year[8] - Net profit excluding non-recurring gains and losses increased by 66.47% to ¥22,818,435.64 from ¥13,707,040.75 in the previous year[8] - Operating profit was CNY 38,243,379.20, an increase of 7.87% year-on-year[24] - Net profit for Q1 2020 was ¥28,569,575.90, a decline of 5.4% from ¥30,198,717.82 in Q1 2019[46] - The company’s total comprehensive income for the period was CNY 28.72 million, slightly lower than CNY 28.76 million in the previous period[49] Cash Flow and Liquidity - Net cash flow from operating activities was negative at -¥13,221,474.71, a decline of 153.43% compared to ¥24,747,299.89 in the same period last year[8] - Cash and cash equivalents decreased by 29.78% to CNY 1,000,529,268.09 due to investments in financial products and cash dividend payments[19] - Cash flow from operating activities showed a net outflow of CNY 13.22 million, contrasting with a net inflow of CNY 24.75 million in the previous period[52] - The cash and cash equivalents at the end of Q1 2020 were ¥968,886,375.46, down from ¥1,390,387,673.98 at the beginning of the period, reflecting a decrease of approximately 30.3%[56] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,540,284,466.87, down 8.17% from ¥2,766,172,039.67 at the end of the previous year[8] - The company's total assets decreased to ¥2,578,010,848.46 from ¥2,809,431,784.77, reflecting a reduction of approximately 8.2%[42] - Total liabilities decreased to ¥378,278,545.88 from ¥401,066,022.41, a reduction of about 5.7%[42] - The total current liabilities decreased to 366,135,762.29 yuan from 380,291,624.07 yuan, reflecting a decrease of approximately 3.7%[38] Shareholder Equity - Net assets attributable to shareholders decreased by 8.91% to ¥2,132,430,176.81 from ¥2,341,063,352.38 at the end of the previous year[8] - The company's total equity decreased to 2,154,084,991.08 yuan from 2,362,829,202.10 yuan, a decline of about 8.8%[39] - The equity attributable to shareholders decreased to ¥2,199,732,302.58 from ¥2,408,365,762.36, a decline of approximately 8.7%[42] Operational Challenges - The company faced significant challenges due to the COVID-19 pandemic, affecting production, sales, and supply chain operations[24] - The company has adjusted its annual operational plans to mitigate the adverse effects of the pandemic and ensure normal operations[26] - The company reported a loss of ¥3,589,641.46 due to donations related to the COVID-19 pandemic[9] Government Support and Donations - The company received government subsidies amounting to ¥3,952,502.56 during the reporting period[9] - The company donated a total of 5 million yuan for COVID-19 prevention, including 4 million yuan in cash to the China Charity Federation[29] Research and Development - Research and development expenses increased to ¥14,666,882.72, up from ¥13,600,577.90, indicating a growth of about 7.8% year-on-year[45] - Research and development expenses rose to CNY 11.26 million, an increase of 8.01% compared to CNY 10.42 million in the previous period[48] Financial Management - Financial expenses showed a significant decrease of 864.93% due to increased exchange gains from the rising USD exchange rate[20] - The company has implemented measures to manage currency risk and monitor the impact of the pandemic on overseas exports[27]